Variant report
Variant | nsv520571 |
---|---|
Chromosome Location | chr6:160700769-160704943 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:13)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:13 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CTCF | chr6:160702051-160702153 | Kidney_OC | kidney: | n/a | n/a |
2 | CTCF | chr6:160700660-160700810 | NHEK | skin: | n/a | n/a |
3 | CUX1 | chr6:160703536-160703812 | K562 | blood: | n/a | n/a |
4 | FOS | chr6:160700881-160701234 | MCF10A-Er-Src | breast: | n/a | n/a |
5 | FOS | chr6:160700947-160701147 | MCF10A-Er-Src | breast: | n/a | n/a |
6 | FOS | chr6:160700937-160701186 | MCF10A-Er-Src | breast: | n/a | n/a |
7 | FOS | chr6:160700857-160701219 | MCF10A-Er-Src | breast: | n/a | n/a |
8 | FOSL2 | chr6:160700869-160701221 | A549 | lung: | n/a | n/a |
9 | GATA3 | chr6:160703832-160704147 | SH-SY5Y | brain: | n/a | n/a |
10 | SETDB1 | chr6:160700898-160701441 | U2OS | brain: | n/a | n/a |
11 | STAT3 | chr6:160700920-160701008 | MCF10A-Er-Src | breast: | n/a | n/a |
12 | STAT3 | chr6:160702330-160702629 | MCF10A-Er-Src | breast: | n/a | n/a |
13 | STAT3 | chr6:160700952-160700966 | MCF10A-Er-Src | breast: | n/a | n/a |
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
SLC22A2 | TF binding region |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs2634658 | chr6:160700769-160700770 | Enhancers Flanking Active TSS | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs141901884 | chr6:160700784-160700785 | Enhancers Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs557255963 | chr6:160700820-160700821 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs573660091 | chr6:160700829-160700830 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs147035786 | chr6:160700835-160700836 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs561716233 | chr6:160700838-160700839 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs2634659 | chr6:160700858-160700859 | Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs572986412 | chr6:160700866-160700867 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs369000372 | chr6:160700872-160700873 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs545572543 | chr6:160700898-160700899 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs604258 | chr6:160700899-160700900 | Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs370917970 | chr6:160701077-160701078 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs544564078 | chr6:160701164-160701165 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs2774225 | chr6:160701181-160701182 | Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs547433660 | chr6:160701187-160701188 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs532683981 | chr6:160701195-160701196 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs56914471 | chr6:160701208-160701209 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs114847731 | chr6:160701214-160701215 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs552327295 | chr6:160701253-160701254 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs560166440 | chr6:160701300-160701301 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs73784343 | chr6:160701335-160701336 | Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs500199 | chr6:160701403-160701404 | Inactive region | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs571336310 | chr6:160701411-160701412 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs505111 | chr6:160701424-160701425 | Inactive region | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs558332887 | chr6:160702063-160702064 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs568939912 | chr6:160702096-160702097 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs538005655 | chr6:160702101-160702102 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs554736108 | chr6:160702107-160702108 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs574731528 | chr6:160702108-160702109 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs540509453 | chr6:160702115-160702116 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs148332261 | chr6:160702119-160702120 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs183064075 | chr6:160702150-160702151 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs2484243 | chr6:160702332-160702333 | Inactive region | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs577103153 | chr6:160702352-160702353 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs146171483 | chr6:160702361-160702362 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs2250219 | chr6:160702422-160702423 | Inactive region | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs2774222 | chr6:160702476-160702477 | Inactive region | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs35699579 | chr6:160702501-160702502 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs397817157 | chr6:160702502-160702503 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs112036282 | chr6:160702508-160702509 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs577476452 | chr6:160702534-160702535 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs545292 | chr6:160702545-160702546 | Inactive region | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs556517503 | chr6:160702547-160702548 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs531056128 | chr6:160702555-160702556 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs562521799 | chr6:160702557-160702558 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs113992223 | chr6:160702567-160702568 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs540846320 | chr6:160702574-160702575 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs571012423 | chr6:160703635-160703636 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs2774219 | chr6:160703639-160703640 | Inactive region | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21637783 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Ependymoma | 16718352 | CNVD |
Gastric cancer | 17908304 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 16272173 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Malignant melanoma | 18718029 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Breast cancer | 21858162 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 17603634 | CNVD |
Developmental delay | 19490664 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Leukemia | 18688285 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Malignant melanoma | 17260012 | CNVD |
Prostate cancer | 18632612 | CNVD |
Lung cancer | 18438408 | CNVD |
Soft tissue tumor | 16732325 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Breast cancer | 17850661 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 20556506 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Developmental delay | 21147756 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Developmental delay | 19459884 | CNVD |
Hearing loss | 19459884 | CNVD |
Microcephaly | 19459884 | CNVD |
Coronary artery disease | 17160897 | CNVD |
Chordoma | 18071362 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:160699800-160701200 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
2 | chr6:160700200-160700800 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
3 | chr6:160700200-160700800 | Enhancers | HMEC | breast |
4 | chr6:160700400-160700800 | Flanking Active TSS | NHEK | skin |
5 | chr6:160700800-160701400 | Enhancers | NHEK | skin |